[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100532447":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":13,"studyPopulation":13,"armGroups":21,"interventions":27,"overallOfficials":13,"centralContacts":33,"locations":39,"responsibleParty":73,"collaborators":13,"id":77,"slug":13,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":78,"sex":84,"minAge":85,"maxAge":13,"enrollmentInfo":86,"targetDuration":13,"studyType":89,"phases":90,"briefSummary":91,"conditions":92,"keywords":13,"overallStatus":42,"whyStopped":13,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"University of Tartu","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"Rate of correctly predicted cases of acute mesenteric ischaemia","Rate of correctly predicted cases of Acute mesenteric ischaemia using different biomarkers","10 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":17,"primaryPurpose":18,"observationalModel":13,"timePerspective":13,"maskingInfo":19},"NA","SINGLE_GROUP","Sequential blood samples will be collected from study subjects","DIAGNOSTIC",{"masking":20,"maskingDescription":13,"whoMasked":13},"NONE",[22],{"label":23,"type":6,"description":24,"interventionNames":25},"Patient with suspicion of acute mesenteric ischaemia","Bolld samples is the only intervention. All patients with suspicion of AMI will be included and blood samples collected",[26],"Diagnostic Test: Sequential blood samples",[28],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":13},"DIAGNOSTIC_TEST","Sequential blood samples","Sequential blood samples for diagnostic tests is the only intervention in thei study",[23],[34],{"name":35,"role":36,"phone":37,"phoneExt":13,"email":38},"Annika Reintam Blaser, PhD","CONTACT","+3725142281","annika.reintam.blaser@ut.ee",[40,57],{"facility":41,"status":42,"city":43,"state":13,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Tartu University Hospital","RECRUITING","Tartu","50406","Estonia","EE",{"type":48,"coordinates":49},"Point",[50,51],26.72509,58.38062,{"lat":51,"lon":50},[54],{"name":55,"role":36,"phone":56,"phoneExt":13,"email":13},"Joel Starkopf, PhD","+3727318405",{"facility":58,"status":42,"city":59,"state":13,"zip":60,"country":61,"countryCode":62,"cosmosGeoPoint":63,"geoPoint":67,"contacts":68},"Lucerne Cantonal Hospital","Lucerne","6000","Switzerland","CH",{"type":48,"coordinates":64},[65,66],8.30635,47.05048,{"lat":66,"lon":65},[69],{"name":70,"role":36,"phone":71,"phoneExt":13,"email":72},"Juan Celi de la Torre, MD","+41412051886","juan.celidelatorre@luks.ch",{"type":74,"investigatorFullName":75,"investigatorTitle":76,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"PRINCIPAL_INVESTIGATOR","Annika Reintam Blaser","Associate Professor","100532447",false,"NCT06212921","Biomarkers in Prediction of AMI","Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)","BIPAMI","Inclusion Criteria:\n\n* Age 18 years or older\n* Initial decision in favour of further diagnostics of mesenteric ischaemia\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Consent declined by patient or next of kin (delayed consent)\n* Chronic mesenteric ischaemia without an acute event\n* Immediate decision for withdrawal of further diagnostics and active treatment\n* Referral from another hospital with already established diagnosis of AMI\n* AMI diagnosed at surgery without previously having been considered","ALL","18 Years",{"count":87,"type":88},250,"ESTIMATED","INTERVENTIONAL",[15],"Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.",[93],"Acute Mesenteric Ischemia","2024-11-27",{"date":96,"type":97},"2024-12-03","ACTUAL",{"date":99,"type":97},"2024-10-14",{"date":101,"type":88},"2025-12",{"name":5,"class":6},2]